TCOT
AUTL

Trust Company of Toledo’s Autolus Therapeutics AUTL Stock Holding History

Trust Company of Toledo’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,265
Closed -$56.2K – 781
2025
Q1 		$56.2K Hold
36,265
– – 0.01% 234
2024
Q4 		$85.2K Hold
36,265
– – 0.01% 232
2024
Q3 		$132K Hold
36,265
– – 0.02% 231
2024
Q2 		$126K Hold
36,265
– – 0.02% 227
2024
Q1 		$231K Hold
36,265
– – 0.04% 207
2023
Q4 		$234K Hold
36,265
– – 0.04% 202
2023
Q3 		$84.5K Buy
+36,265
New +$103K 0.02% 207

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Trust Company of Toledo's AUTL Position: Q2 2025 in Review

Trust Company of Toledo sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 36,265 shares — an estimated $56.2K sold.

Trust Company of Toledo first reported a position in AUTL in Q3 2023 and held it in 7 quarters. The position peaked at $234K in Q4 2023. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • Trust Company of Toledo reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Trust Company of Toledo sold 36,265 Autolus Therapeutics shares in Q2 2025, an estimated $56.2K.
  • Trust Company of Toledo first reported a position in Autolus Therapeutics in Q3 2023 and held it in 7 quarters.
  • Trust Company of Toledo's Autolus Therapeutics position peaked at $234K in Q4 2023.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on Trust Company of Toledo's 13F filing for Q2 2025, filed 24 Jul 2025.